About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Updates in MDS
Treatment Updates in MDS
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
F
Addressing Iron Overload in Transfusion Dependent LR-MDS: Mechanisms, Consequences, and Management
By
Francesca Vinchi
62 views
January 5, 2023
0 Comments
Login to view comments.
Click here to Login
Treatment Updates in MDS
05:27
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 …
Feat.
M. Della Porta
19:18
John Bennett
Diagnosing and Prognosis for MDS in 2023: A Morphologist's Pers…
17:00
UChicago Medicine
Pathologist's Perspective on Diagnosing MDS-RS
Feat.
J. Cheng
27:52
Indy Hematology Review
The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS
Feat.
R. Stone
32:10
Total Health
MDS in 2023: Updates in Diagnosis and Treatment
Feat.
A. Shastri
21:38
MDS Foundation
Anemia and Transfusion Dependence in MDS: Effects and Optimization S…
Feat.
R. Buckstein
19:57
Yale Cancer Center
Yale Cancer Center Selected Updates in MDS
Feat.
A. Zeidan
07:17
Sangeetha Venugopal
Management and Treatment of Lower-Risk MDS
23:33
Francesca Vinchi
Addressing Iron Overload in Transfusion Dependent LR-MDS: Mechanisms…
14:09
Moshe Mittelman
Current Treatment Options in Management of Anemia in LR-MDS: 1L and …
06:55
ASH 2022 Conference Coverage
Luspatercept for Treatment of LR-MDS: Real World Data Replicates MED…
Feat.
R. Komrokji
06:06
ASH 2022 Conference Coverage
Synergistic Activity of Luspatercept and Erythroid Stimulating Agent…
Feat.
R. Komrokji
19:03
Talha Badar
Low Risk-MDS: Background, Treatment Options, and Case Presentation
11:15
SOHO 2022 Tenth Annual Meeting
Next Questions: Myelodysplastic Syndromes
Feat.
G. Garcia-Manero
08:11
ASH 2022 Conference Coverage
Validation of 2022 WHO & ICC Classifications in MDS - An Analysi…
Feat.
S. Ball
31:13
ASH 2022 Conference Coverage
Selected Updates in MDS
Feat.
A. Zeidan
05:09
ASH 2022 Conference Coverage
MEDALIST Study: Multiple Episodes of Transfusion Independence With L…
Feat.
U. Platzbecker
16:39
Current Challenges in Hematology
LR-MDS 2023: Standards and Perspectives
Feat.
U. Platzbecker
16:56
Current Challenges in Hematology
Targeting Inflammation in LR-MDS
Feat.
A. Sophie Kubasch
